Ethical Issues in the Treatment of Addiction
Addiction or dependence to a psychoactive substance – or drug – is a biopsychosocial disorder. Many aspects of addiction can be clinically treated, yet this raises some important ethical issues. The health and social problems resulting from addiction are generally influenced by sociopolitical agendas and prevailing views about addiction, and therefore, we make some brief observations about how these affect the act, manner, or method of treating someone who is addicted.
In this chapter, we focus on some recent developments in the treatment of addiction: pharmacological approaches, and invasive brain therapies. In addition to giving an ethical overview of these, we look more generally at the justification for coerced treatment.
KeywordsDeep Brain Stimulation Relapse Prevention Addiction Treatment Opioid Dependence Drug Court
- American Psychiatric Association. (1994). DSM-IV: Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.Google Scholar
- American Psychiatric Association. (2012). DSM-V: The future of psychiatric diagnosis. Available at: http://www.dsm5.org/Pages/Default.aspx. Accessed April 2012.
- Australian National Council on Drugs (ANCD). (2012). Position statement: Naltrexone sustained release preparations (injectible & implants). http://www.ancd.org.au/images/PDF/Positionstatements/naltrexonepositionstatement.pdf. Accessed April 2012.
- Carter, A., & Hall, W. (2012). Addiction neuroethics: The promises and perils of neuroscience research on addiction. London: Cambridge University Press.Google Scholar
- Courtwright, D. (2001). Forces of habit: Drugs and the making of the modern world. Cambridge, MA: Harvard University Press.Google Scholar
- Dean, A. J., Saunders, J. B., Jones, R. T., Young, R. M., Connor, J. P., & Lawford, B. R. (2006). Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence. Journal of Psychiatry & Neuroscience, 31(1), 38–45.Google Scholar
- Engel, G. (1980). The clinical application of the biopsychosocial model. The American Journal of Psychiatry, 137, 535–544.Google Scholar
- Harwood, H., & Myers, T. (2004). New treatments for addiction: Behavioural, ethical, legal, and social questions. Washington, DC: National Academies Press.Google Scholar
- Hasin, D. (1994). Treatment/self-help for alcohol-related problems: Relationship to social pressure and alcohol dependence. Journal of Studies on Alcohol, 55, 660–666.Google Scholar
- Hubbard, R. (1989). Drug abuse treatment: A national study of effectiveness. London: University of North Carolina Press.Google Scholar
- Kass, L. (2003). Beyond therapy: Biotechnology and the pursuit of happiness. Washington, DC: President’s Council on Bioethics.Google Scholar
- Koob, G., & Le Moal, M. (2006). Neurobiology of addiction. New York: Academic.Google Scholar
- Krupitsky, E., & Blokhina, E. A. (2010). Long-acting depot formulations of naltrexone for heroin dependence: A review. Current Opinion in Psychiatry. doi:10.1097/YCO.0b013e3283386578.Google Scholar
- Maastricht University Medical Centre (2009). A phase 2B, multi-center, randomized, double-blinded, parallel-arm, study to assess efficacy and safety of 3′-Aminomethylnicotine-P. Aeruginosa r-Exoprotein A conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) as an aid in smoking cessation. http://clinicaltrials.gov/ct2/show/NCT00995033. Accessed 6 Oct 2010.
- Medvedev, S., Anichkov, A., & Poltakov, I. (2003). Physiological mechanisms of the effectiveness of bilateral stereotactic cingulotomy in treatment of strong psychological dependence in drug addiction. Fiziologiia Cheloveka, 29, 117–123.Google Scholar
- Murray, T. (2004). Ethical issues in immunotherapies or depot medications for substance abuse. In H. J. Harwood & T. G. Myers (Eds.), New treatments for addiction: Behavioral, ethical legal and social questions (pp. 188–212). Washington, DC: National Academies Press.Google Scholar
- Pedic, F. (1990). Drug use in prisons: Data collection procedures. A review and recommendations. Sydney: National Drug and Alcohol Research Centre.Google Scholar
- Skog, O. (2003). Addiction: Definitions and mechanisms. In N. Heather & R. E. Vuchinich (Eds.), Choice, behavioural economics and addiction. Oxford: Elsevier.Google Scholar
- Stathis, H. (1991). Drug use among offenders: A literature review. Research and Statistics Digit, NSW Department of Corrective Services.Google Scholar
- Ward, J., Mattick, R., & Hall, W. (1992). Key issues in methadone maintenance treatment. Kensington: New South Wales University Press.Google Scholar
- Ward, J., Mattick, R., & Hall, W. (1998). Methadone maintenance treatment and other opioid replacement therapies. Sydney: Harwood Academic Press.Google Scholar